Physician profile
Ashley Hall
NPI 1174058432
$6,920.14
in general payments reported to CMS, 2019-2025
41 companies · $1,838 in 2025
The $1,838 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2022: $1,320 · 2023: $1,657 · 2024: $1,765 · 2025: $1,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,166 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,165.53 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,082.20 | 2021-2025 | |
| Pfizer INC. | $741.42 | 2021-2025 | |
| Lilly USA, LLC | $635.07 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $557.32 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Neurocrine Biosciences, INC. | $532.99 | 2022-2025 | Ingrezza |
| Glaxosmithkline, LLC. | $528.06 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $352.10 | 2022-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $246.29 | 2023-2025 | Rexulti |
| Ferring Pharmaceuticals INC. | $232.54 | 2021-2022 | |
| Exact Sciences Corporation | $208.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $198.28 | 2023-2025 | Veozah |
| Abbott Laboratories | $187.99 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sumitomo Pharma America, INC. | $186.01 | 2023-2025 | Gemtesa, Myfembree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.18 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $145.18 | 2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.